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STEM CELLS AND REGENERATION RESEARCH ARTICLE
BMP signaling regulates satellite cell-dependent postnatal muscle
growth
Amalia Stantzou1,2,3, Elija Schirwis1,3,4, Sandra Swist5,6, Sonia Alonso-Martin3,7, Ioanna Polydorou1,2,
Faouzi Zarrouki1, Etienne Mouisel3,8, Cyriaque Beley9, Anaïs Julien10, Fabien Le Grand3, Luis Garcia1,
Céline Colnot10, Carmen Birchmeier4, Thomas Braun5, Markus Schuelke2, Frédéric Relaix3,7
and Helge Amthor1,11,*
ABSTRACT
Postnatal growth of skeletal muscle largely depends on the expansion
and differentiation of resident stem cells, the so-called satellite cells.
Here, we demonstrate that postnatal satellite cells express
components of the bone morphogenetic protein (BMP) signaling
machinery. Overexpression of noggin in postnatalmice (to antagonize
BMP ligands), satellite cell-specific knockout of Alk3 (the gene
encoding the BMP transmembrane receptor) or overexpression of
inhibitory SMAD6 decreased satellite cell proliferation and accretion
during myofiber growth, and ultimately retarded muscle growth.
Moreover, reduced BMP signaling diminished the adult satellite cell
pool. Abrogation of BMP signaling in satellite cell-derived primary
myoblasts strongly diminished cell proliferation and upregulated the
expression of cell cycle inhibitors p21 and p57. In conclusion, these
results show that BMP signaling defines postnatal muscle
development by regulating satellite cell-dependent myofiber growth
and the generation of the adult muscle stem cell pool.
KEY WORDS: BMP signaling, Postnatal muscle growth, Satellite
cells, Muscle stem cells, Mouse
INTRODUCTION
The basic cellular units of skeletal muscle are myofibers, which are
multinuclear syncytia capable of contraction. Myofibers, which are
generated during prenatal development, continue to grow after birth
(White et al., 2010). This postnatal growth requires a sufficiently
large pool of muscle precursors, the so-called satellite cells, which
reside between the basal lamina and the sarcolemma of muscle
fibers (Mauro, 1961). During the first 3 weeks of postnatal mouse
development, muscle fibers grow through the recruitment of
satellite cells (accretion), thereby enlarging the number of
myonuclei, as well as expanding the cytoplasmic domain.
Thereafter, muscle fibers grow mainly by expanding their
cytoplasmic volume without further addition of myonuclei (White
et al., 2010). Whereas postnatal satellite cells cycle to generate
progenitors for fusion with the muscle fibers, they are quiescent in
adult muscle and are only reactivated for the regeneration of
damaged muscle fibers (Beilharz et al., 1992). The postnatal growth
period is accompanied by a steady decline in the number of muscle
satellite cells until 21 days after birth and remains stable thereafter
throughout adulthood (White et al., 2010).
Little is known about the intercellular signaling systems that guide
postnatal muscle growth and determine adult satellite cell number. We
and others have previously described the crucial role of bone
morphogenetic proteins (BMPs) during embryonic, fetal and adult
muscle growth (Amthor et al., 1998, 1999, 2002; Hirsinger et al., 1997;
Ono et al., 2011; Pourquié et al., 1996; Sartori et al., 2013;Wang et al.,
2010). In parallel with other members of the TGFβ family of signaling
molecules, BMPs act on target cells via transmembrane serine/
threonine kinase receptors. BMPs bind to type II and type I receptors,
and form a ligand-receptor complex that permits the phosphorylation
of the type I receptor via the constitutively active type II receptor (Nohe
et al., 2004, 2002). The type I receptor in turn phosphorylates the
BMP-responsive Smad1/5/8 proteins. Phosphorylated Smad1/5/8
proteins subsequently form complexes with co-Smad4 and
translocate into the nucleus to regulate transcriptional activity of
target genes such as DNA-binding protein inhibitors (Ids) (Miyazono
and Miyazawa, 2002). Four isoforms of these proteins (Id1-4) block
the binding of E proteins with the myogenic regulatory transcription
factor MyoD and inhibit terminal differentiation (Jen et al., 1992).
Interestingly, BMP signaling upregulates the inhibitory Smad6 as part
of a negative feedback loop. Smad6 interferes with BMP signaling at
the level of the receptor, aswell as at the level of the complex formation
between receptor-regulated Smad1 and the common mediator
co-Smad4 (Goto et al., 2007).
A number of secreted proteins, such as noggin (Nog), can non-
covalently bind BMPs, thereby impeding their receptor binding
(Amthor et al., 2002; Krause et al., 2011). The BMP/Nog
antagonism regulates satellite cell lineage progression. We have
previously demonstrated in vitro that BMP signaling stimulated
proliferation of activated adult satellite cells and inhibited myogenic
differentiation, whereas abrogation of BMP signaling via addition
of Nog, induced precocious differentiation (Ono et al., 2011).
Interestingly, myotube formation is delayed in Nog-null mice,
pointing to a requirement for Nog expression for proper muscle
differentiation (Tylzanowski et al., 2006). Moreover, injection of
Nog into regenerating muscle inhibited BMP signaling and reduced
P-Smad1/5/8, Id1 and Id3 protein levels (Clever et al., 2010).Received 30 August 2016; Accepted 21 June 2017
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Based on our previous in vitro findings (Ono et al., 2011), we set
out to determine the role of BMP signaling on satellite cells in vivo.
We chose the early postnatal/juvenile growth phase of mouse limb
muscles as our main experimental model because satellite cell
activation, proliferation and differentiation, as well as fiber growth,
can be much more easily observed when compared with
regeneration models. We used three independent techniques to
interfere with BMP signaling in satellite cells: (1) addition of Nog,
which interferes at the ligand level; (2) abrogation of the BMP
transmembrane receptor Alk3, which interferes at the receptor level;
and (3) overexpression of SMAD6, which interferes with BMP
signaling at the cell-autonomous level. We show that abrogation of
BMP signaling severely inhibits satellite cell activity, myonuclear
recruitment and the generation of the adult satellite cell pool.
RESULTS
BMP signaling is active in postnatal muscle satellite cells
We first asked whether the BMP signaling pathway is active during
the postnatal growth phase of skeletal muscle. We found the
presence of transcripts of genes encoding different BMP ligands, the
BMP receptor Alk3 (also known as Bmpr1a), the BMP target gene
Id1 (Miyazono and Miyazawa, 2002), as well as the BMP
antagonists Nog, Grem1, Fst and Chrd (respectively encoding for
Nog, gremlin 1, follistatin and chordin) in total RNA extracted from
limb skeletal muscle of 3- ,14-, 21- and 28-day-old mice (Fig. S1A).
Generally, the mRNA concentrations for BMP signaling
components declined from postnatal to young adult stages.
In order to identify whether satellite cells respond to BMP
signaling, we monitored the nuclear accumulation of BMP-induced
Smad1/5 proteins in Pax7-positive nuclei using double
immunohistochemistry. We discovered P-Smad1/5-positive and
-negative satellite cells in postnatal, juvenile and young adult
muscle (from 3-, 14-, 21- and 28-day-old mice) (Fig. 1). We also
found P-Smad1/5-positive nuclei that were negative for Pax7, which
mainly were myonuclei within myofibers, as judged from their
position.
We next examined the time frame and dynamics of the response
of satellite cells to BMPs. For this, satellite cells were isolated from
6- to 8-week-old mice by magnetic-activated cell sorting (MACS)
and expanded in culture, which maintained Pax7 expression in
nearly 100% of cells in all the described conditions. Cells were then
submitted to a serum-free culture condition supplemented with
soluble Alk3 receptor for 6 h, thereby removing residual BMP
ligands otherwise likely present in the culture medium. Thereafter,
culture medium was replaced with serum-free medium containing
100 ng/ml of BMP4 for 1 h, which increased nuclear levels of
phosphorylated Smad1/5 protein in the cells (Fig. S1B,C), clearly
indicating that they respond to BMP signaling. Additionally, by
performing a time course study, we found that Id1 mRNA copy
numbers peaked 1 h after BMP4 exposure and slowly declined
thereafter (Fig. S1D). Interestingly, in control cultures, Id1
expression increased slowly following medium change from Alk3
pre-treatment to vehicle supplemented control medium (not
containing Alk3), suggesting that cells synthesize BMPs and
therefore respond to BMP signaling in an autocrine/paracrine
fashion. This hypothesis was further supported by the finding that
Id1 mRNA copy numbers in serum-deprived control cells could be
further halved through addition of sAlk3, which sequestered the
satellite cell-derived BMPs.
Having found that satellite cells activate the BMP signaling
cascade, we next studied the expression of BMP signaling
components in FACS-isolated muscle satellite cells from 3-, 14-,
Fig. 1. BMP signaling activity in satellite cells
during postnatal muscle growth. Sample
images of immunohistochemistry to monitor
phosphorylated Smad1/5 (p-Smad1/5) expression
(red) in Pax7-expressing satellite cells (green).
Muscle sections were obtained from the tibialis
anterior (TA) muscle of postnatal wild-type mice at
P3, P14, P21 and P28 (panels from top to bottom).
DAPI (blue) was used as a nuclear stain. All three
channels (green, red and blue) were merged
together with a differential interference contrast
image (DIC), in which the individual fibers can be
visualized. Cells that co-express p-Smad1/5 and
Pax7 are highlighted with arrows. Scale bar:
50 µm.
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21- and 28-day-old mice. We found that satellite cells expressed
transcripts of all BMP signaling components, as demonstrated
above for whole-muscle extracts with the exception of only Bmp14
(Fig. 2). Interestingly, mRNA expression levels were generally more
than 10 times higher in satellite cells than in total muscle extracts
(Fig. S1A). In total muscle extracts, the decline of satellite cell-
specific gene expression signatures with muscle maturation towards
day P21 can well be explained by a dilution effect due to the overall
reduction of satellite cell number by 65% between days P6 and P21
(White et al., 2010). Expression levels of several genes encoding
BMP signaling components in satellite cells, such as Alk3, Id1 and
Nog, transiently decreased at P14, whereas expression of others
decreased from postnatal to adult stages or remained steady (Fig. 2).
Among the different analyzed BMP ligands, Bmp6wasmost strongly
expressed and expression peaked in adult satellite cells. These results
suggest that BMP signaling plays a role during satellite cell-
dependent postnatal muscle growth; however, there is no general rule
in their expression dynamics during muscle maturation.
The BMP antagonist Nog retards postnatal satellite cell-
dependent muscle growth
We next interrupted the BMP signaling cascade during postnatal
muscle growth in vivo and ectopically overexpressed the BMP
antagonist Nog by transfecting the whole muscle using an AAV-
expressing vector. Tibialis anterior (TA) and triceps brachii (TB)
muscles were transfected at P3 with an AAV-Nog, which resulted in
high transgene expression (Fig. S2A). We have previously shown
that AAV strongly transfects differentiated muscle fibers. However,
as Nog is a secreted protein it would accumulate in the extracellular
space. Nog overexpression significantly retarded muscle growth
when compared with saline injected controls, which could be
verified by anatomical analysis of skeletal muscle at 4 weeks of
age (Fig. 3A). The muscle weight of Nog-treated muscles was
considerably smaller than the weight of control limbs (Fig. 3B).
Indeed, TB, TA and EDL (extensor digitorum longus) muscle
weights were reduced by 15%, 21% and 23%, respectively.
Morphometric analysis of single fibers or of transverse sections
from TA muscles revealed a strong shift of myofiber diameters
towards smaller fiber sizes (Fig. 3C and Fig. S2B,E), whereas fiber
length remained unchanged (Fig. S2C), which is evidence for
postnatal fiber growth retardation. Postnatal skeletal muscle
enlarges via continuous recruitment of satellite cells into the
growing myofiber syncytium. Hence, the total number of myonuclei
in one fiber reflects the cumulative history of previous satellite cell
activity. In order to understand the cellular mechanism that results in
Nog-induced growth retardation, we determined the total number of
myonuclei on isolated muscle fibers from TA muscles prior to and
after Nog overexpression. Prior to Nog transfection at day P3,
muscle fibers contained 74±2 myonuclei, which increased in
control muscles to 419±11 myonuclei, whereas Nog-treated
myofibers increased the number of their myonuclei to only 244±5
(mean±s.e.m.) (Fig. 3D and Fig. S2D). Thus, whereas the number of
myonuclei increased by 5.7-fold between days P3 and P28 in
controls, the presence of Nog reduced the increase to 3.3-fold,
indicating that satellite cell function during postnatal myofiber
growth might be impaired.
The BMP antagonist Nog decreases postnatal satellite cell
activity
We next studied the effect of Nog on satellite cell proliferation
during the postnatal growth phase. We treated mice at P3 with AAV-
Nog, administered BrdU at P14 for 3 consecutive days and analyzed
muscles at P17. The state of the muscle precursor cells was
subsequently determined using anti-Pax7 and anti-BrdU
immunostaining: Pax7+/BrdU+ marking proliferating satellite
cells, Pax7+/BrdU− marking quiescent satellite cells and Pax7−/
BrdU+ with subsarcolemmal position marking former satellite cells
that had divided and differentiated to become mitotically inactive
once recruited into the myofiber (Fig. 4A). Interestingly, we found
that the total number of Pax7+ cells was reduced after Nog-mediated
Fig. 2. Expression dynamics of BMP
signaling pathway components in
satellite cells during postnatal muscle
growth. The relative mRNA copy
numbers per 103 Gapdh mRNA copies of
different BMP ligands (Bmp2, Bmp4,
Bmp5, Bmp6, Bmp7, Bmp13 and
Bmp14), BMP receptor type I Alk3, BMP
target gene Id1, BMP antagonists Nog
(encoding Noggin), Grem1 (encoding
gremlin), Fst (encoding follistatin) and
Chrd (encoding chordin) in satellite cells
that were isolated by FACS from skeletal
muscles of wild-type mice (n=3 biological
and technical replicates) at P3, P14, P21
and P28. Data are mean±s.e.m.
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abrogation of BMP signaling (Fig. 4B). Moreover, all three Pax7+/
BrdU+, Pax7+/BrdU− and Pax7−/BrdU+ cell populations were
reduced after AAV-Nog treatment (Fig. 4B). Decreased satellite cell
proliferation was thus the main cellular mechanism that caused
reduced myonuclear recruitment and reduced postnatal muscle
growth. Indeed, the precocious differentiation of satellite cells
would be unlikely, as the number of newly formed myonuclei was
reduced. Moreover, the reduction of the Pax7+/BrdU− population
suggested a decrease of satellite cell self-renewal and thus a decline
of the satellite cell pool in states of abrogated BMP signaling.
At about 21 days of age, the final satellite cell number is
established and does not further increase towards adulthood (White
et al., 2010). We therefore wanted to investigate the consequence of
this decreased satellite cell proliferation during the postnatal stages
for the generation of the adult muscle stem cell pool. Remarkably,
treatment with Nog at day P3 decreased the reservoir of satellite cells
at 4 weeks of age to about half the size of controls when counting
Pax7+ and cadherin+ cells (Fig. 4C,D and Fig. S2E). In summary,
these findings demonstrate that adult muscle stem cells are
generated during the postnatal growth phase under the control of
BMP signaling.
Conditional Alk3 knockout results in reduced postnatal
muscle growth and a reduced satellite cell reservoir
In order to evaluate the role of BMP signaling in activated satellite
cells during postnatal muscle growthmore specifically, we tested the
consequence of cell-autonomous abrogation of the BMP signaling
pathway by ablating Alk3, the BMP type I receptor, exclusively
in postnatal Pax7-expressing satellite cells. This aim was achieved
by generating Pax7CreERT2/+;Alk3flox/flox mice and inducing the
Alk3 knockout by administering tamoxifen at postnatal days P7
and P9. We analyzed the effect of Alk3 knockout on muscle
growth at 4 weeks of age in comparison with genetic controls
(tamoxifen injected Alk3flox/flox mice). Tamoxifen treatment of
Pax7CreERT2/+;Alk3flox/flox pups resulted, just like Nog treatment, in
muscle fiber hypotrophy. Indeed, morphometric fiber size analysis
of transverse cross-sections from TA muscles revealed a shift
towards smaller fiber sizes (Fig. 5A,B). Similar to theNog treatment,
isolated EDL myofibers from tamoxifen-treated 4-week-old
Pax7CreERT2/+;Alk3flox/flox mice contained significantly fewer
myonuclei than their respective controls (Fig. 5C). Furthermore,
the number of Pax7+ satellite cells was also decreased in tamoxifen-
treated Pax7CreERT2/+;Alk3flox/flox mice when compared with
controls (Fig. 5D).
Overexpression of SMAD6 inhibits satellite cell-dependent
postnatal muscle growth and the generation of the adult
satellite cell pool
We additionally tested a different means for cell-autonomous
abrogation of BMP signaling during postnatal muscle growth via
overexpression of SMAD6, an inhibitory Smad of the intracellular
BMP signaling cascade, specifically in Pax7-expressing
satellite cells. Such time- and lineage-specific expression of
SMAD6 was achieved by crossing Pax7CreERT2/+ mice with
Rosa26Lox-Stop-Lox-huSMAD6-IRES-EGFP (RS6) mice and subsequent
activation of the transgene by tamoxifen through removal of a stop
codon. SMAD6mRNA expression, taken as evidence for successful
Cre-induced recombination (Fig. S2F), was found only in satellite
cell-derived myoblasts from tamoxifen-treated Pax7CreERT2/+;
RS6+/− mice, but not from control mice. We administered
tamoxifen to Pax7CreERT2/+;RS6+/− mice at P7 and P9, and
analyzed the effect on muscle growth at 4 weeks of age in
comparison with genetic controls (tamoxifen-treated RS6+/− mice),
thus using the same experimental protocol as for the Alk3 knockout.
Tamoxifen treatment of Pax7CreERT2/+;RS6+/− pups resulted in
muscle fiber hypotrophy, similar to Nog treatment and Alk3
knockout. Indeed, morphometric fiber size analysis of transverse
cross-sections from TA muscles revealed a shift towards smaller
fiber sizes in tamoxifen-treated Pax7CreERT2/+;RS6+/− mice when
compared with controls, indicating that the decrease of muscle
growth results from a failure to increase the myofiber size (Fig. 6A,
B). Importantly, this failure of muscle fiber growth was not
compensated for during later development. Indeed, myofibers
were still smaller in 2-month-old tamoxifen-treated Pax7CreERT2/+;
RS6+/− mice when compared with controls (Fig. S2G-I). Moreover,
isolated EDL myofibers from tamoxifen-treated, 4-week-old
Pax7CreERT2/+;RS6+/− mice contained fewer myonuclei than their
respective controls (Fig. 6C), whereas the myonuclear domain of the
Fig. 3. Consequences of Nog-mediated abrogation of BMP signaling for
postnatal muscle growth. Triceps brachii (TB) muscle and the anterior
compartment of the lower hindlimb were transduced with AAV-Nog at P3.
Muscleswere analyzed at 4weeks of age. (A) Dorsal viewof the forelimb shows
significantmuscle hypotrophy (arrowheads) of theAAV-Nog-treated TBmuscle
(right) when compared with the control saline-injected contralateral side (left).
Sample images of n=4 injected mice. Scale bar: 1 cm. (B) Dot plots depict
muscle wet weight of TB, TA and EDL muscles. Horizontal lines represent the
median. (C) Histogram of the fiber diameters of 4-week-old TA muscle,
analyzed on mid-belly muscle sections following immunostaining against
laminin. Dashed lines represent the fitted normal distribution. (D) Thenumberof
myonuclei per single fiber of the TAmuscle at P3 (n=50 fibers from 3mice) and
at P28 following AAV-Nog (n=120 fibers from3mice) or saline (n=68 fibers from
3mice) injections at P3. Data are depicted asWhiskers-Tukey box plots. Boxes
indicate the interquartile range (IQR), the horizontal line indicates the median,
whiskers indicate [1.5 × IQR] and dots indicate the outliers.
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fibers remained unchanged (Fig. 6D). These results suggest
decreased satellite cell activity during the postnatal muscle growth
phase in satellite cells that lack BMP signaling. Indeed, the number
of Pax7+ satellite cells, if quantified on both muscle cross-sections
or isolated fibers, was decreased in tamoxifen-treatedPax7CreERT2/+;
RS6+/− mice when compared with controls (Fig. 6E,F). Finally, the
satellite cell pool remained decreased by 75% when 8-week-old TA
muscles from tamoxifen-treated Pax7CreERT2/+;RS6+/− mice were
compared with control muscles (Fig. S2J). This can be taken as
further evidence that adult satellite cells are generated during the
postnatal growth phase under the control of BMP signaling.
Expression of SMAD6 in myonuclei does not alter satellite
cell and myonuclear number
The aforementioned experiments failed to provide unequivocal
evidence of whether the SMAD6-mediated cell-autonomous
inhibition of BMP signaling was the sole cause for the observed
decrease in the numbers of satellite cells and myonuclei. As an
alternative explanation, the inclusion of SMAD6-overexpressing
myonuclei may indirectly influence satellite cell activity. Hence, we
generated HSA-Cre+;RS6+/− mice to overexpress SMAD6
exclusively in terminally differentiated myofibers. Muscles from
these mice expressed SMAD6 as well as GFP, suggesting the
effective recombination of the transgene (Fig. S3A,B). Of note, GFP
could be detected only on western blot and not using fluorescence
analysis of dissected muscles in toto or of sectionedmuscle (data not
shown). Histological analysis of cross-sections of TA muscles from
4- and 8-week-old HSA-Cre+;RS6+/−mice revealed a normal tissue
architecture (Fig. S3C). Importantly, the number of Pax7+ satellite
cells did not change in 4- and 8-week-old HSA-Cre+;RS6+/− mice
when compared with controls (Fig. S3D,E). Taken together, these
experiments ruled out an indirect effect of SMAD6-overexpressing
myonuclei on satellite cells and therefore confirm that BMP
signaling acts in a cell-autonomous manner in satellite cells.
BMP signaling is required for myoblast activation and
proliferation
We next used in vitro cell culture to further explore the role of BMP
signaling on satellite cell-derived muscle precursor cells. Cultures
of FACS-sorted satellite cells from adult forelimb and hindlimb
Pax7CreERT2/+;RS6+/− muscles were treated either with 1 μM
hydroxytamoxifen (4-OHT) to evaluate the cell-autonomous
effect of SMAD6 upregulation or with 50 ng/μl recombinant Nog
to antagonize BMP ligands present in the culture medium (Fig.
S4A). The 4-OHT-treated cells strongly expressed SMAD6, but not
the cells from untreated control cultures (Fig. 7A). Furthermore, 4-
Fig. 4. Effects of Nog-mediated abrogation of BMP signaling on postnatal satellite cell activity. The anterior compartment of the lower hindlimb was
transduced with AAV-Nog at P3. At P14, the mice were treated for 3 consecutive days with subcutaneous injections of BrdU and were sacrificed at P17.
(A) Fluorescence images of a mid-belly transverse section of a TA muscle following immunostaining against Pax7 in red (arrows), against BrdU (green) and
against laminin (white); nuclei were stained with DAPI (blue). Pax7+/BrdU+ cells are indicated with white arrows. Pax7+/BrdU− satellite cells and Pax7−/BrdU+
sublaminal myonuclei are, respectively, indicated with red and green arrows. Scale bar: 20 µm. (B) The diagrams depict the number of Pax7+, Pax7+BrdU−
and Pax7+BrdU+ satellite cells, as well as the number of newly recruited Pax7−BrdU+ myonuclei per 100 myofibers from the TA muscle. n=4 biological replicates
for each condition. (C,D) The anterior compartment of the lower hindlimb was transduced with AAV-Nog at P3. Muscles were analyzed at 4 weeks of age.
The diagram depicts the number of Pax7+ (C) and of m-Cadherin+ (D) satellite cells per 100 myofibers quantified from whole TA muscle sections (n=3 or 4 for
saline-injected control; n=3 for AAV-Nog-injected muscle). Horizontal lines represent the median and dots represent individual data points.
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OHT and Nog downregulated the BMP target gene Id1 (Fig. 7B).
These results demonstrate the efficacy of the 4-OHT-induced
recombination in Pax7CreERT2/+;RS6+/− satellite cells and the value
of Nog as a positive control for abrogation of BMP signaling.
We then assessed cell proliferation by monitoring clonal cell
expansion after seeding cells at low density. After 5 days in culture,
cells expressed MyoD (Fig. S4B) and lost expression of Pax7 (data
not shown), which highlights the transition from satellite cells to
committed myoblasts. Both treatment schemes with 4-OHT or with
Nog reduced the number of satellite cell-derived myoblast
progenitors below 50% of the control values (Fig. 7C). In a
control experiment, 4-OHT revealed some inhibiting effect (the
number of cells per colony was reduced by 14%) on cell
proliferation on its own when treating FACS-isolated Pax7CreERT2/+
cells. However, this effect was less pronounced than the severe
inhibition by Nog or by 4-OHT (the number of cells per colony was
reduced by 58% for both treatments) on Pax7CreERT2/+;RS6+/−-
derived cells (Fig. 7C).
The reduction of cell numbers could not be accounted for by
induction of apoptosis because none of the cells under these culture
conditions expressed the apoptosis marker cleaved-caspase 3 (data
not shown). Furthermore, we found similar proportions of cells
expressing myogenin (MyoG) and myosin heavy chain (MHC) in
Pax7CreERT2/+;RS6+/−-derived cultures treated with 4-OHT and Nog
if compared with control cultures (Fig. 7D,E and Fig. S4B-D). This
confirmed that the inhibition of BMP signaling does not affect cell
lineage progression. Finally, we observed that the number of
proliferating Ki67+ cells was decreased by 53% upon treatment with
4-OHT and by 45% with Nog (Fig. 7F and Fig. S4B,E). The
decreased proliferation was associated with an increase in transcript
levels for the cell cycle inhibitors p57 and p21, suggesting a cell
cycle arrest as the likely molecular mechanism following abrogation
of BMP signaling (Fig. 7G,H).
DISCUSSION
The present study has provided several important new insights about
BMP signaling and its contribution to the regulation of satellite cell-
dependent muscle growth in postnatal skeletal muscle. We show
that postnatal satellite cells express in vitro as well as in vivo
components of the BMP signaling pathway and respond to BMP
signaling. These findings are reminiscent of previous observations
on the role of BMP during embryonic and fetal chicken myoblast
development and during adult murine satellite cell regulation
(Amthor et al., 1998, 1999, 2002; Ono et al., 2011; Wang et al.,
2010). We thus conclude that BMP signaling is an important
regulator of muscle stem cell activity during all stages of muscle
development.
We used AVV-vectors encoding Nog, an efficient antagonist of
BMP2, BMP4, BMP5, BMP6, BMP7, BMP13 and BMP14 (all
found to be expressed by satellite cells, with the exception of
BMP14), as a means to abrogate BMP signaling (Krause et al.,
2011). AAV highly transfects muscle fibers following intramuscular
injection. Our working hypothesis was that Nog would mainly be
synthesized and secreted from muscle fibers, thereby changing the
signaling environment, including that of satellite cells by
antagonizing locally present BMPs. We do not know whether
AAV-Nog also transfected satellite cells. However, as the transgene
remains episomal, it does not replicate during cell division and
would be rapidly diluted among the muscle cell progenitors. We
show that Nog-mediated BMP blockade decreased satellite cell
proliferation, which well explains decreased myonuclear accretion
during postnatal myofiber growth. However, our in vivo
experiments using AAV-mediated Nog overexpression could not
exclude the possibility of secondary effects on satellite cells, i.e. a
change of signaling of the myofiber back to the satellite cells.
We thus used three different inducible Cre-lox systems to either
ablate the expression of BMP receptor Alk3 or to overexpress the
BMP intracellular inhibitor SMAD6 in either satellite cells or
differentiated muscle fibers. Both means of cell-autonomous
inhibition of BMP signaling (Alk3 knockout or SMAD6
overexpression) targeted to satellite cells resulted in smaller fibers
containing fewer myonuclei and in reduced satellite cell number.
We know little about the satellite cell progeny in our loss-of-
function models. Our BrdU experiments suggest that satellite cells
do not precociously differentiate and that they decline in number
because of diminished proliferation. However, direct proof remains
missing as the IRES-EGFP cassette of the recombined Smad6 locus
in Pax7CreERT2/+;RS6+/− satellite cells was too weakly expressed to
allow cell fate tracking. Thus, we cannot exclude other cellular
mechanism such as apoptosis.
To address this issue further, we tested loss-of-function strategies
in vitro. We confirmed diminished proliferation as being
responsible for the insufficient progenitor generation. We did not
find evidence, either in vivo or in vitro, of precocious differentiation
of myogenic precursors after inhibition of the BMP pathway, which
Fig. 5. Consequences of Alk3 knockout in satellite cells on postnatal
muscle growth. Mice were injected with tamoxifen (TXF) at P7 and P9, and
sacrificed at the age of 1 month. (A,B) Quantification of the diameter of TA
muscle fibers [depicted as Whiskers-Tukey box plots (A) and as a histogram
(B)] of mid-belly muscle sections following immunostaining against laminin,
from control tamoxifen-treated Alk3flox/flox mice (n=4, gray) compared with
tamoxifen-treated Pax7CreERT2/+;Alk3flox/flox mice (n=4, white). (C) The
Whiskers-Tukey box plots depict the number of myonuclei per isolated muscle
fiber from EDL muscles from control tamoxifen-treated Alk3flox/flox mice
(n=49 fibers from 3 mice) compared with tamoxifen-treated Pax7CreERT2/+;
Alk3flox/flox mice (n=77 fibers from 3 mice). Boxes indicate the interquartile
range (IQR), the horizontal line indicates the median, whiskers indicate
[1.5 × IQR] and dots indicate the outliers. (D) The dot plot (median indicated by
the horizontal line) depicts the number of Pax7+ satellite cells per 100 muscle
fibers from TA muscles from control tamoxifen-treated Alk3flox/flox mice (n=5,
black dots) compared with tamoxifen-treated Pax7CreERT2/+; Alk3flox/flox mice
(n=6, white dots).
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stands in contrast to previous findings obtained from satellite cell
cultures (Ono et al., 2011). We can only speculate about the reasons
underlying such discrepancy. Possibly, the effect ofNog aswell as of
SMAD6 on the BMP target gene Id1 in our study was too small to
alter MyoD transcriptional activity and myogenic lineage
progression. Of note, our study lacks experimental proof of
whether BMP signaling worked via Id1 to impinge on MyoD
(Myod1) or on other targets. Moreover, previous work demonstrated
unchanged satellite cell number in uninjured muscles following Id
knockout (Clever et al., 2010). Thus, our finding that BMP signaling
alters Id1 expression was useful to demonstrate that BMP signaling
was active in cells; however, it offered no explanation of the
downstream molecular mechanism. Recent work demonstrated that
myogenic proliferation and differentiation can be decoupled (Zalc
et al., 2014). In agreement,we found here, followingSmad6-induced
abrogation of BMP signaling, increased expression of cell cycle
inhibitors, notably of p57 (Cdkn1c), which is known to increase stem
cell quiescence in conjunction with a decreased proliferation rate
(Matsumoto et al., 2011); however, myogenic progression towards
myogenin and MHC expression was not altered. This offers a
molecular mechanism for the function of BMPs on muscle stem
cells, which remains to be explored in detail.
Interestingly, BMP signaling could modulate other signaling
cascades, as recently demonstrated for Notch signaling, which
becomes activated by BMP-induced Smad1/5 binding to the
promoter of the Notch target gene HES1 in colorectal cancer cells
(Irshad et al., 2017). Such BMP-Notch signaling crosstalk, being
independent of Id1, could contribute to our observed phenotypes as
Notch signaling is a crucial regulator of satellite cell function
(Fukada et al., 2011). The dependence of satellite cells on additional
signaling systems could well explain why our loss-of-function
strategies did not completely abolish satellite cell activity and
myofiber growth.
We show that cell-autonomous abrogation of BMP signaling
targeted to satellite cells slowed but did not stop accretion of
myonuclei. Resulting myofibers, therefore, consist of a mosaic of
non-recombined and recombined myonuclei, once recombined
satellite cells fuse into the syncytium. This, on the one hand, could
signal back on the satellite cells. On the other hand, it could itself
retard myofiber growth. Importantly, targeted overexpression of
SMAD6 to differentiated muscle (HSA-Cre+;RS6+/− mice) did not
affect the number of myonuclei and satellite cells per fiber, thereby
providing clear evidence for a direct effect of BMP signaling in
satellite cells in vivo. Moreover, the myonuclear domain remained
unchanged in muscle fibers from Pax7CreERT2/+;RS6+/− mice,
suggesting that the cytoplasmic volume per nucleus increased
normally during the postnatal growth phase (White et al., 2010).
This result stands in contrast to our previous work, which showed, in
adult muscle, that decreased BMP signaling causes myofiber
atrophy (Sartori et al., 2013).
Whereas we here show smaller satellite cell numbers in
Pax7CreERT2/+;Alk3flox/flox mice, the number remained unchanged
in Myf5Cre;Alk3flox/flox mice (Huang et al., 2014). This implies that
other BMP receptors or signaling pathways other than BMP may
Fig. 6. Consequences of SMAD6-mediated abrogation of BMP signaling in neonatal satellite cells on juvenile muscle growth. Mice were injected
with tamoxifen (TXF) at P7 and P9, and sacrificed at the age of 1 month. (A,B) Quantification of the diameter of TAmuscle fibers [depicted asWhiskers-Tukey box
plots (A) and as a histogram (B)] of mid-belly muscle sections following immunostaining against laminin, from control tamoxifen-treated RS6+/−mice (n=5, gray)
compared with tamoxifen-treated Pax7CreERT2/+;RS6+/−mice (n=4, white). (C) TheWhiskers-Tukey box plots depict the number of myonuclei per isolated muscle
fiber from EDL muscles from control tamoxifen-treated RS6+/− mice (n=51 isolated fibers from 3 mice) compared with tamoxifen-treated Pax7CreERT2/+;RS6+/−
mice (n=66 isolated fibers from 4 mice). Boxes indicate the interquartile range (IQR), the horizontal line indicates the median, whiskers indicate [1.5 × IQR] and
dots indicate the outliers. (D) TheWhiskers-Tukey box plots depict the myonuclear domain analyzed on segments of isolated single fibers from control tamoxifen-
treated RS6+/− mice (n=98 segments from 33 fibers) compared with tamoxifen-treated Pax7CreERT2/+;RS6+/− mice (n=182 segments from 61 fibers). (E) The
Whiskers-Tukey box plots depict the number of Pax7+ satellite cells per isolatedmuscle fiber fromEDLmuscles from control tamoxifen-treatedRS6+/−mice (n=51
fibers from 3 mice) compared with tamoxifen-treated Pax7CreERT2/+;RS6+/− mice (n=73 fibers from 4 mice). Boxes indicate the interquartile range (IQR), the
horizontal line indicates the median, whiskers indicate [1.5 × IQR] and dots indicate the outliers. (F) The dot plot (median indicated by the horizontal line) depicts
the number of Pax7+ satellite cells per 100muscle fibers from TAmuscles from control tamoxifen-treatedRS6+/−mice (n=6, black dots) compared with tamoxifen-
treated Pax7CreERT2/+;RS6+/− mice (n=8, white dots).
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compensate for the deficit in Alk3 in satellite cells. This would be in
line with our findings, as Alk3 loss of function in Pax7CreERT2/+;
Alk3flox/flox mice resulted in a rather modest effect.
It is now common knowledge that adult muscle satellite cells are
of somite origin (Relaix andMarcelle, 2009), but how the expansion
of the satellite cell pool is controlled andwhich factors determine the
final number of quiescent satellite cells in the adult stage was
unknown.Here, we show that BMP signaling controls the generation
of adult satellite cells during the postnatal growth phase. We suggest
that BMPs maintain precursor proliferation to generate a sufficiently
large precursor cell pool, and cells become quiescent once BMP
signaling is withdrawn during muscle maturation.
The exact source and identity of BMPs that control postnatal
satellite cell activity remain unknown. Here, we show the presence
of BMP transcripts in satellite cells at different time points of
postnatal development. However, the respective roles of the various
BMPs synthesized by satellite cells and from other sources remain
to be determined.
Fig. 7. Quantitative analysis following abrogation of BMP signaling in cultured Pax7CreERT2/+;RS6+/− satellite cell-derived primary myoblasts.
Experimental protocol: at day 0, satellite cells from Pax7CreERT2/+ or Pax7CreERT2/+;RS6+/− adult mice were isolated using FACS and cultured in proliferation
media; from days 2-4, cells remained either untreated (control), or were treated with 1 μM hydroxytamoxifen (4-OHT) or with 50 ng/ml of recombinant mouse
Nog protein; at day 5, cells were either fixed for immunocytochemistry or collected for RNA extraction. (A,B) The dot plots (median indicated by the horizontal line)
depict the relative mRNA copy numbers per 103 Gapdh mRNA of human SMAD6 (A) or of the BMP target gene Id1 (B) from cultured satellite cells isolated
from Pax7CreERT2/+;RS6+/− mice. (C) Cells were cultured at low density for a proliferation assay for the comparison of non-treated versus treated satellite cells
isolated by FACS from skeletal muscles of Pax7CreERT2/+ and Pax7CreERT2/+;RS6+/− mice. The number of cells per colony was counted from at least three
wells per condition and per mouse (three mice); at least 50 colonies of cells per condition and per mouse were quantified. Data are shown as Whiskers-Tukey
box plots. All P values were calculated using a t-test. (D-F) Following cultures of satellite cells from Pax7CreERT2/+;RS6+/− mice, the number of positive cells
is given as a percentage of the total number of stained cells per colony following immunostaining against (D) myogenin (MyoG), (E) myosin heavy chain
(MHC) and (F) Ki67. The quantification was performed on 13 to 20 colonies per culture (n=3 cultures, each derived from cells isolated from onemouse, total of n=3
mice). Data are shown asWhiskers-Tukey box plots. AllP values were calculated using a t-test. In C-F, boxes indicate the interquartile range (IQR), the horizontal
line indicates the median, whiskers indicate [1.5 × IQR] and dots indicate the outliers. (G,H) Dot plots (median indicated by the horizontal line) depict the relative
mRNA copy numbers per 103 Gapdh mRNA of (G) p21 and (H) p57 from FACS-isolated and cultured satellite cells from Pax7CreERT2/+;RS6+/− mice. Cells
remained either untreated (control, n=4) or were treated with 1 μM 4-OHT (n=3) or 50 ng/ml of recombinant mouse Nog protein (n=3).
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Abnormally high levels of BMP signaling in skeletal muscle
can trigger ectopic bone formation, as seen in individuals suffering
from fibrodysplasia ossificans progressiva (Shore et al., 2006).
Interestingly, myogenic precursors contribute only minimally to
BMP-mediated heterotopic ossification (<5%) in vivo (Lounev et al.,
2009). Using AAV-mediated overexpression of Bmp4, we observed
an important ossification of soft tissue in the hindlimbs of adult mice
after 4 weeks of treatment (data not shown), which is similar to the
effects previously reported in the literature (Lounev et al., 2009).
Ectopic overexpression of BMP4 likely caused uncontrolled high
ligand levels that initiated the osteogenic program in skeletal muscle.
Our results suggest that source, type of BMP ligands, presence of
antagonists and expression of receptors must be tightly coordinated
to allow correct muscle growth and homeostasis. It remains to be
determined whether and how satellite cell-derived BMPs signal to
neighboring cells and whether this defines the respective position of
satellite cells within their niche. Future BMP gain-of-function
experiments and ligand-specific knockout are required to elucidate
the role of specific ligands. In conclusion, BMP signaling is an
important regulatory pathway during postnatal muscle growth and
determines satellite cell-dependent myofiber growth and the size of
the adult muscle satellite cell pool.
MATERIALS AND METHODS
Animals
Rosa26-LoxP-Stop-LoxP-huSMAD6-IRES-EGFP transgenic mice (on a
C57BL/6J background), also labeled RS6, were crossbred with the different
Cre-driver mice described below. The generation of this mouse line is
described in the supplementary Materials and Methods. Pax7CreERT2/+
knock-in mice [JAX strain name is B6;129-Pax7tm2.1(cre/ERT2)Fan/J]
were crossbred with wild-type C57BL/6J mice. This strain expresses CRE-
ERT2 recombinase from the endogenous Pax7 locus (Lepper et al., 2009).
By crossing Pax7CreERT2/+ with the RS6 strain, we obtained Pax7CreERT2/+;
RS6+/− offspring. Transgenic HSA-Cre mice [JAX strain name FVB.Cg-Tg
(ACTA1-cre)79Jme/J on a C57BL/6J background] have the Cre
recombinase gene driven by the human α-skeletal actin (HSA) promoter
(Miniou et al., 1999). By crossing these mice with the RS6 strain, we
obtained HSA-Cre+/−; RS6+/− offspring. Alk3flox/flox mice (JAX strain name
is Bmpr1atm2.1Bhr) contain LoxP sites flanking exon 2 of Alk3 (Mishina
et al., 2002). By crossing Alk3flox/flox with Pax7CreERT2/+;Alk3flox/+, we
obtained Pax7CreERT2/+;Alk3flox/flox offspring. The mice were bred in the
animal facility of either the Medical Faculty of Paris VI or the Imagine
Institute and were kept according to institutional guidelines. Wild-type
C57BL/6J mice were purchased from Janvier or Charles River. Animal
studies have been approved and were carried out under the laboratory and
animal facility licenses.
AAV-injection
AAV quantity for intramuscular delivery was calculated relative to total
body weight [x(in µl)=1.5×body weight (in g)], which was between 5 and
30 µl. AAV was injected into the triceps brachii muscle or into the muscles
of the anterior compartment of the lower leg of 3-day-old C57BL/6J mice.
Control muscles were either non-injected or injected with PBS as stated in
the text and legends. As in previous work, we never observed any effect on
muscle morphology or histology in control injected animals when injecting
PBS intramuscularly with the exception of some regenerating fibers along
the injection trajectory (Sartori et al., 2013). AAV-Nog was used at a
concentration of 1×10E13 viral genomes (vg)/ml. The plasmid construction
and AAV production procedures are described in the supplementaryMaterials
and Methods. At 4 weeks of age, muscles were isolated and prepared for
cryosections/histology, qPCR or isolation of single muscle fibers.
Tamoxifen injection for induction of Cre-ERT2 activity
Tamoxifen (Sigma) was prepared in heated corn oil (Sigma) at 37°C at
20 mg/ml and 2.5 μl/g were administered by intra-peritoneal injection into
pups (P7 and P9), which were sacrificed at the ages of 1 or 2 months. Adult
mice (for primary myoblast cultures, see below), between 2 and 4 months of
age, were injected with 100 μl daily for 5 days, and were sacrificed 1 week
after the first injection.
FACS isolation and culture of satellite cells
For fluorescent-activated cell sorting, muscles (forelimb, hindlimb,
abdominal, pectoral) were processed from P3, P14, P21 and P28 mice.
The dissection of the muscles was performed with care to take off as much
fat and connective tissue as possible. The muscles were minced in Hank’s
Balanced Salt Solution (HBSS) supplemented with 0.2% bovine serum
albumin, 1% penicillin-streptomycin in a sterile 6 cm Petri dish on ice. The
minced muscles were digested for 1.5 h at 37°C with 2 μg/ml collagenase A
(Roche), 2.4 U/ml dispase I (Roche), 10 ng/ml DNase I (Roche), 0.4 mM
CaCl2 and 5 mM MgCl2 in supplemented HBSS. Cells were washed with
supplemented HBSS, filtered through a 100 μm cell strainer and pelleted.
The washing step was repeated with 70 μm and finally 40 μm cell strainers.
For labeling extracellular markers, the following primary antibodies were
used (10 ng/ml): rat anti-mouse CD45-PE-Cy7 (BD), rat anti-mouse
Ter119-PE-Cy7 (BD), rat anti-mouse CD34-BV421 (BD), rat anti-mouse
integrin-α7-A700 (R&D Systems) and rat anti-mouse Sca1-FITC (BD).
Cells were washed once with ice-cold supplemented HBSS, filtered and re-
suspended in supplemented HBSS. Flow cytometric analysis and cell
sorting were performed on a FACSAriaII (BD) previously calibrated
(Fluorescence Minus One and use of compensation beads) using the Lumic-
CyPS UPMC platform. TER119 (LY76)+ and CD45 (PTPRC, LY5)+ cells
were negatively selected, CD34+ and integrin-α7+ cells were positively
selected and the remaining cells were gated based on SCA1− expression.
The selected cells were collected in a FACS tube containing lysis buffer and
were directly processed for RNA extraction as described below.
Culture of satellite cell-derived primary myoblasts using the pre-
plating method
Cells from adult muscle tissue, prepared in a similar way to the method used
for the FACS purification procedure, were resuspended in growth medium
(see FACS procedure) and pre-plated onto a non-coated 15 cm Petri dish for
4 h (fibroblasts will adhere to the plate, whereas most myoblasts will remain
in suspension). The media contained myoblasts in suspension and was
transferred onto gelatin-coated 10 cm Petri dishes. Cultures were maintained
in growth medium until cells reached 70% confluency, after which cells
were harvested by trypsinization for RNA extraction.
MACS isolation and culture of satellite cells
Satellite cells were isolated from forelimb, hindlimb and back muscles of 6-
to 8-week-old female C57BL/6 mice using the skeletal muscle dissociation
kit (Miltenyi Biotech, 130-098-305) followed by magnetic-activated cell
sorting (MACS). MACS separation involved an initial enrichment step
using the mouse satellite cell isolation kit (Miltenyi Biotech, 130-104-268)
followed by further purification with mouse anti-integrin α-7 microbeads
(Miltenyi Biotech, 130-104-261). Isolated cells were plated on growth factor
reduced matrigel (Corning)-coated dishes in medium containing DMEM
(Gibco), 15% FBS (Gibco), 2.5 ng/ml basic FGF (Sigma), 10 ng/ml
leukemia inhibitory factor (BioChrom) and 1% Pen/Strep (Gibco), and
maintained in a humidified hypoxic 3% O2/5% CO2 atmosphere at 37°C.
After the first 24 h in culture, 1× B27 without vitamin A (Gibco) was added
to the medium. Following a 2-day culture period, which permitted sufficient
expansion of the satellite cells without loss of Pax7 positivity, cells were
treated with 100 ng/ml recombinant human BMP4 (R&D Systems, 314-BP)
or with the vehicle used to reconstitute BMP4 (4 mM HCl containing 0.1%
bovine serum albumin) in a serum-free medium. Prior to incubation with
BMP4, cells were switched to a serum-free medium for 6 h to eliminate the
effect from unknown BMP signaling components in the serum. Where
specified, BMP soluble receptor (recombinant mouse BMPR-IA/ALK3-Fc
Chimera, R&D Systems, 437-MR) in a concentration of 200 ng/ml was
added to the medium to block residual BMP signaling components.
Following cell harvest, cells were immediately lysed and total RNA was
extracted using the RNeasy Micro kit (Qiagen). Reverse transcription was
performed using SuperScript III Reverse Transcriptase (Invitrogen).
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Quantitative real-time PCR (RT-qPCR) was performed on the 7000
Sequence Detection System (Applied Biosystems) using SYBR Green I
detection chemistry (Applied Biosystems).
RNA isolation and real-time PCR
Total RNA from frozen muscle tissue was isolated using Trizol (Invitrogen)
extraction in combination with RNeasy Mini kit (Qiagen). Total RNA from
FACS-isolated satellite cells was isolated using the RNAqueous Microkit
(Ambion kit, Life Technologies). Total RNA from cultured primary
myoblasts was isolated using the RNeasy Micro kit (Qiagen). In all cases,
RNase-Free DNase I Set (Qiagen or Life Technologies) was used to
eliminate traces of DNA in the RNA extract. Isolated RNA was quantified
using NanoVue Plus GE HealthCare spectrophotometer (Dutscher). For
RNA extracted from muscle tissue and from cultured myoblasts, cDNA
synthesis was performed using the ThermoScript RT-PCR system
(Invitrogen) with random hexamer primers for first-strand cDNA
synthesis. For RNA extracted from FACS-isolated satellite cells, cDNA
synthesis was performed using SuperScript VILO Master Mix (Invitrogen).
Real-time polymerase chain reaction (RT-qPCR) was performed according
the SYBR Green protocol (BioRad) in triplicate on the CFX96 Touch Real-
Time detection system (BioRad) using iTaq Universal SYBR Green
Supermix (BioRad). Alternatively, reverse transcription was performed
using SuperScript III Reverse Transcriptase (Invitrogen), followed by RT-
qPCR on the 7000 Sequence Detection System (Applied Biosystems) using
SYBR Green I detection chemistry (Applied Biosystems). A 10 min
denaturation step at 94°C was followed by 40 cycles of denaturation at 94°C
for 10 s and annealing/extension at 60°C for 30 s. Before sample analysis,
we had determined for each gene and primer set the PCR efficiencies with a
standard dilution series (10E1-10E7 copies/μl), which subsequently enabled
us to determine the copy numbers from the Ct values. mRNA levels were
normalized to 10E3 or 10E6 copies of Gapdh mRNA. Fold changes were
calculated according to the efficiency corrected −ΔΔCt method (Pfaffl,
2001). The sequences for the primers used are listed in Table S1.
Immunocytochemistry/immunohistochemistry
Immunocytochemistry/histological analyses were performed using primary
antibodies against Pax7 (1/50 mouse IgG1 from DSHB or alternatively 1/2
mouse IgG1 DSHB-hybridoma cell supernatant), pSmad1/5 (1/50, rabbit,
Cell Signaling, 9516), laminin (1/400, rabbit, Dako, Z0097), anti-BrdU
(1/100, rat, Abcam, ab6326), m-Cadherin (1/50, mouse IgG1, Nanotools,
0106-100), MyoD (1/100, rabbit IgG1, Santa Cruz Biotechnology, sc760),
myogenin (1/100, mouse IgG1, DSHB), panMHC (mouse Ig2a, A4-1025,
DSHB), Ki67 (1/100, mouse IgG1, BD Biosciences, 556003) and cleaved-
caspase 3 (1/300, Cell Signaling, 9664), followed by secondary antibodies
with various fluorophores (Alexa Fluor 1/400 goat anti-mouse IgG1 488 or
594, goat anti-rabbit 488 or 594) and DAPI (1/1000 or 1/5000, Sigma).
Fluorescence was visualized using a Zeiss Axio Imager with an Orkan
camera (Hamamatsu) and AxioVision software.
Fluorescence intensity quantification
All parameters during image acquisition were kept the same. Fluorescence
intensity was quantified using ImageJ software. The background was
removed and the regions of interest (ROIs; in this case nuclei) were
identified using the software ‘Nucleus Counter’ plug-in. ‘Integrated
Density’ and ‘Area’ measurements were performed for each nucleus and
the corrected fluorescence intensity was calculated as follows: corrected
fluorescence intensity=integrated density÷area.
BrdU analysis
Mice were treated with AAV-Nog or AAV-control, which were
intramuscularly injected into the tibialis anterior (TA) muscle at P3. At
P14, animals were labeled with BrdU (Invitrogen) by subcutaneous
injection with 10 µl per 1 g body weight for 3 consecutive days.
Following sacrifice, histological sections of the TA muscle (12 µm) were
fixed with 4% paraformaldehyde for 10 min and permeabilized with
methanol (−20°C) for 6 min. Antigens were retrieved by boiling for 30 min
at 70-80°C in 0.01 M sodium nitrate (pH 6). This was followed by
incubation with HCl (1 N) for 20 min at 37°C. Samples were washed in PBS
and incubated for 1 h in blocking buffer (2% BSA and 2% porcine serum).
Samples were incubated overnight at 4°C with anti-BrdU (rat, Abcam) in
combination with other primary antibodies (see above).
Western blot
Proteins were extracted from frozen triceps brachii muscle using RIPA buffer
with a proteinase and phosphatase inhibitor cocktail (Complete tablets,
Roche). Proteins were separated through denaturating SDS-polyacrylamide
gel electrophoresis with the Laemmli system and transferred onto
nitrocellulose membranes using the wet method (BioRad). The blots were
probed using primary antibodies against GFP (1/5000, Aves Labs) andActin
(1/10000, Sigma). Western blots were analyzed with SuperSignal West Pico
Chemiluminescent substrate (Pierce).
Single fiber preparation
Mice were sacrificed at P3 and P28. TA and extensor digitorum longus (EDL)
muscles were surgically isolated. Muscles were thereafter digested in 0.2%
collagenase type 1dissolved inDMEM(LifeTechnologies). Individual, viable,
undamaged myofibers were isolated by gently passing them through Pasteur
pipettes with different sized apertures as described in detail elsewhere (Moyle
and Zammit, 2014). Then the myofibers were fixed in 4% paraformaldehyde
dissolved in PBS (Sigma) for 10 min, washed, stained against Pax7 (1/50,
mouse IgG1, DSHB) and with DAPI, and mounted on slides.
Morphometric studies
Cryosections of 12 μm of ΤΑ muscles were stained with anti-laminin to
delineate the muscle fibers and anti-Pax7 or anti-m-Cadherin to label
satellite cells. Fluorescent photographs were taken with a ×20 objective on a
microscope (Zeiss, AxioImage) and saved as TIFF files. These images were
projected onto a flatscreen coupled with a graphic tablet, which enabled the
manual retracing of the muscle fiber outlines and the counting of satellite
cells. The fibers of the entire muscle cross-section were analyzed.
For myonuclear domain analysis, single fibers were stained with Pax7 and
DAPI. Images of at least three different segments of each fiber were acquired
with a ×40 objective on a microscope (Zeiss, AxioImage) and the number of
Pax7− nuclei was quantified. The volume of each fiber segment was then
assessed on the acquired images by measuring with ImageJ software the
length (L) of the fiber segment and the fiber diameter (D) as follows:
volume=π×(D÷2)2×L. The myonuclear domain was then calculated as
follows: myonuclear domain=volume÷number of nuclei.
Statistical analysis
The results are expressed as the mean together with the standard error of the
mean (s.e.m.) for qPCR data. Other data are presented as dot plots of the
median or as Whiskers-Tukey box plots. The probability for statistical
differences between two experimental groups was determined through
calculation of the P value using the two-tailed unpaired t-test.
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Figure S1 – (A) Gene expression dynamics of BMP signaling pathway components in 
skeletal muscle from neonatal and juvenile mice. Diagrams depict the relative mRNA copy 
numbers per 103 Gapdh mRNA copies of different BMP ligands (Bmp2, 4, 5, 6, 7, 13, 14), 
BMP type I receptor Alk3, BMP target gene Id1, BMP antagonists Nog (encoding Noggin), 
Grem1 (encoding Gremlin), Fst (encoding Follistatin), and Chrd (encoding Chordin) in 
skeletal muscles from wildtype mice (n=3 biological and n=3 technical replicates) at P3 
(black), P14 (white), P21 (dark grey) and P28 (light grey). Values are shown as mean ± SEM. 
(B-D) Evaluation of BMP responsiveness of satellite cells in vitro. Cultured mouse satellite 
cells, which were MACS isolated, were incubated for 1 hour with vehicle or with 100 ng/ml 
BMP4. Prior to BMP4 stimulation cells were switched for 6 h to serum-free medium 
containing 200 ng/ml soluble Alk3 receptor (sAlk3). This was done to prevent binding of 
BMP ligands that were likely present in the culture medium. (B) Exemplary images of 
immunostainings of MACS-isolated and cultured satellite cells expressing phosphorylated 
Smad1/5 (red) and Pax7 (green). DAPI (blue) was used as a nuclear stain. Scale bar 0.5 µm. 
(C) The Whiskers-Tukey box plot depicts the phosphorylated Smad1/5 fluorescent staining 
intensity per nuclear area in the BMP4 treated as opposed to the Vehicle treated satellite cells. 
A minimum of 200 nuclei was analyzed for each condition. (D) Time course of Id1 mRNA 
expression following 0 h, 0.5 h, 1.0 h, 2.0 h, 3.0 h, and 4.0 h of BMP4 stimulation. Cultured 
mouse satellite cells, which were MACS isolated, were incubated with vehicle (in grey) or 
with 100 ng/ml BMP4 (in black) over the indicated time periods to assess Id1 mRNA 
expression levels. Prior to vehicle or BMP4 treatment, cells were switched to a serum-free 
medium containing 200 ng/ml sAlk3 for 6 h. Three different controls are depicted: non serum 
starved cells (control with serum, in stripes), serum starved cells (control w/o serum, in 
white) and serum starved with sAlk3 (control w/o serum, and with sAlk3, in black dots). 
Values are depicted as mean ± S.E.M (n=3). 
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Figure S2 – (A-E) Consequences of Noggin mediated abrogation of BMP signaling for 
juvenile muscle growth. (A) The diagram presents the gene expression of Nog (chicken 
origin) in muscles from control and AAV-Nog injected mice (two weeks following the 
injection, n=4). Data represent mRNA copies per 103 Gapdh mRNA copies and are shown as 
dot plots (+median). (B) The histogram presents the distribution of myofiber diameter of 
single myofibers isolated from TA muscles of 4-week-old mice. Dashed lines represent the 
fitted normal distribution. n=107 and n=128 myofibers were analyzed, respectively, from 3 
non-injected control and 5 AAV-Nog treated muscles at P3. (C) The Whiskers-Tukey box 
plots depict the myofiber length. n=65 and n=103 myofibers, respectively, from three non-
injected control and five AAV-Nog treated muscles at P3. (D) Exemplary images of isolated 
single fibers of TA muscle from day P3 old mice (left panel) and 4-week-old mice (right 
panel). The inlays show a magnified section of the fibers. Fibers were stained with DAPI and 
tiled images were acquired using an automated microscope. Fluorescent images were 
superimposed over transmission light images. Scale bar 500 µm. (E) Exemplary images of 
immunostaining on a TA muscle of 4-week-old mice. The muscle was injected with saline 
solution (control, left panel) or AAV-Nog treated at P3 (right panel). The images illustrate the 
number of Pax7+ satellite cells (red, arrows) and the size of the myofibers delineated by 
laminin (green). DAPI (blue) was used as a nuclear stain. Scale bar 20 µm. (F-J) 
Consequences of Cre/Lox mediated SMAD6 overexpression in satellite cells. (F) Mice 
were injected with tamoxifen for 5 consecutive days and were sacrificed one week after the 
first tamoxifen injection; skeletal muscles were collected and processed to isolate satellite 
cell-derived primary myoblasts with the pre-plating method; cells were cultured in 
proliferation medium for 4 days after which the RNA was extracted. The image depicts a 
1.5% agarose gel supplemented with ethidium bromide showing the presence or absence of 
the huSMAD6 PCR product (using primers specific for the human sequence). The PCR was 
performed on cDNA synthesized from RNA extracted from cultured satellite cell-derived 
primary myoblasts from either tamoxifen treated Pax7CreERT2/+ control mice (lane 2) or 
tamoxifen treated Pax7CreERT2/+;RS6+/- mice (lane 3). The presence of the band in lane 3 
reflects that recombination occurred under these experimental conditions. Lane 1: 100 bp size 
marker. (G-I) RS6+/- and Pax7CreERT2/+;RS6+/- mice were injected with tamoxifen at P7 and 
P9, and sacrificed at the age of two months. (G) Fluorescence images of mid-belly transverse 
sections of TA muscles from control tamoxifen treated RS6+/- mice in comparison to 
tamoxifen treated Pax7CreERT2/+;RS6+/- mice, immunostaining against Pax7 in red (arrows), 
against Laminin (green), nuclei stained with DAPI (blue). Scale bar 20 μm. (H) Whiskers-
Tukey box plots depict the quantification of the fibers diameters of TA muscle, analyzed on 
mid-belly muscle sections following immunostaining against Laminin, from control 
tamoxifen treated RS6+/- mice (n=3, grey) in comparison to tamoxifen treated 
Pax7CreERT2/+;RS6+/- mice (n=3, white). (I) Histogram presenting the distribution of TA 
muscle fiber diameters. (J) Dot plot (+median) depicts the number of Pax7+ nuclei quantified 
per 100 myofibers on TA mid-belly transverse muscle sections from control tamoxifen treated 
RS6+/- mice (n=3, black circles) in comparison to tamoxifen treated Pax7CreERT2/+;RS6+/- mice 
(n=3, white circles).   
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Figure S3 – Effect of SMAD6 overexpression in differentiated muscle. (A) Image of 
immunoblots showing GFP and actin bands, along with the Ponceau staining as loading 
control. Total proteins were extracted from the triceps muscle of two HSA-Cre+;RS6+/- mice 
and two RS6+/- mice at 1 month of age. (B) The dot plots (+median) depict the relative 
mRNA copy numbers per 106 GAPDH mRNA of huSMAD6. RNA was extracted from the 
gastrocnemius muscle of 1-month-old RS6+/- mice (n=3, black dots) and HSA-Cre+;RS6+/- 
mice (n=5, white dots). (C) Example of hematoxylin and eosin staining (HE, upper panel) on 
mid-belly transverse sections of the TA muscle from 1-month-old control HSA-Cre+ mice 
(left panel) in comparison to HSA-Cre+;RS6+/- mice (right panel). Scale bar 40 μm. Example 
of a fluorescence image (lower panel) following immunostaining against Pax7 (red, arrows), 
against Laminin (green) and nuclei stained with DAPI (blue) of mid-belly transverse sections 
of TA muscle from 2-month-old control HSA-Cre+ mice (left panel) in comparison to HSA-
Cre+;RS6+/- mice (right panel). Scale bar 20 μm. (D) Dot plots (+median) depicting the 
number of Pax7+ satellite cells per 100 myofibers counted on TA mid-belly muscle sections 
from 1-month-old control RS6+/- mice (n=3) in comparison to HSA-Cre+;RS6+/- mice (n=5). 
(E) Dot plots (+median) depicting the number of Pax7+ satellite cells per 100 myofibers 
counted on TA mid-belly muscle sections from 2-month-old control RS6+/- mice (n=4) in 
comparison to HSA-Cre+;RS6+/- mice (n=4).  
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Figure S4 – Analysis of cell proliferation and differentiation following abrogation of 
BMP signaling in cultured Pax7CreERT2/+;RS6+/- satellite cell-derived primary myoblasts. 
(A) Scheme of the experimental protocol: at day 0 satellite cells from Pax7CreERT2/+;RS6+/- 
adult mice were isolated using FACS and cultured in low density with proliferation media; 
from days 2-4 they remained either untreated (control), or were treated with 1 μM 
hydroxytamoxifen (4-OHT) or 50 ng/mL of recombinant mouse Noggin protein (Noggin); at 
day 5 cells were fixed for immunocytochemistry. (B) Representative fluorescence images of 
single colonies in which nuclei stained with DAPI are blue and immunostaining against 
MyoD, myogenin (MyoG), myosin heavy chain (MHC), or Ki67 in red (from top to bottom). 
Scale bar 100 μm. (C-E) Data are shown as cumulative rank ogives of the number of 
myoblasts, in a colony, expressing the protein of interest marked by immunofluorescence. 
Different culture conditions are compared (control in blue, treated with 4-OHT in red and 
treated with Noggin in green). The number of cells that are positively stained for Myogenin 
(MyoG) (C), Myosin heavy chain (D) and Ki67 (E) are plotted on the horizontal axis. The 
vertical axis corresponds to the individual ranks, normalized to the total rank for each 
experiment to permit comparison of data sets of different sample size. The quantification was 
performed on 13 to 20 colonies per culture (n=3 cultures, each derived from cells isolated 
from one mouse, total of n=3 mice).   
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SUPPLEMENTARY METHODS 
Generation of the conditional mouse line Rosa26-LoxP-Stop-LoxP-huSMAD6-IRES-
EGFP (RS6) 
For generation of the conditional SMAD6 overexpressing mouse line, the human SMAD6 
coding sequence present in the Mammalian Expression Clone EX-R0044-M02 (OmicsLink 
™ ORF Expression Clones, Source BioScience) was inserted into the pIRES2EGFP vector 
(Clontech Laboratories). Cloning was enabled by inserting a NheI site into the BstBI site of 
the EX-R0044-M02 upstream of the SMAD6 ORF via the synthetic oligonuctleotide 5’- GAA 
CTG CTA GCA GTT-3’. Next, the NheI/NotI SMAD6_IRESEGFP fragment was subcloned 
into the pBigT vector (Srinivas et al., 2001), which contained the loxP-flanked transcriptional 
STOP-codon combined with a PGK-neomycin cassette for positive selection of transfected 
embryonic stem (ES) cells. Finally, with the help of the enzymes AscI, AccI and PacI, the 
floxedSTOP-huSMAD6-IRES-EGFP fragment was subcloned into the Rosa26-PA vector 
(this vector was modified before by inserting a FseI site for linearization), which contained 
the homologous arms for recombination in the ROSA26 locus and a PGK-DTA (Diptheria 
Toxin A) cassette for negative selection in ES cells (Srinivas et al., 2001; Soriano, 1999).  
The FseI-linearized floxedSTOP-huSMAD6-IRES-EGFP containing ROSA26 targeting 
vector was electroporated into V8.1 ES cells (129/FVB hybrid), G418 selected (400 µg/ml) 
and resulting clones characterized by Southern blot analyses using the 5’ external probe 
“R26-5probeB” on EcoRV digested genomic ES cell DNA. The “R26-5probeB” probe was 
amplified from genomic DNA with the primers R26-5probeB_fwd: 5’-GTG GGG TCG ACT 
AGA TGA AGG-3’and R26-5probeB_rev: 5’-CTC ACG GGT ACG GGC CAT TCC-3’). 
Positive clones were injected into C57Bl/6 blastocysts and those implanted into foster mice.  
Injection of ES cell clone #7 gave rise to chimeras, which transmitted the mutant ROSA26 
allele to the next generation by mating to C57Bl/6 mice. For genotyping, DNA was extracted 
from or mouse tails. PCR was used to determine the genotype of the ROSA26 allele with the 
primers (Rosa-FA: 5’-AAA GTC GCT CTG AGT TGT TAT-3’; Rosa-RF: 5’-GGA GCG 
GGA GAA ATG GAT ATG-3’, Rosa-SpliceAC: 5’-CAT CAA GGA AAC CCT GGA CTA 
CTG-3’). The amplified product of the mutant locus spans 249 base pairs (bp) while the 
product of the wildtype locus spans 585 bp. 
AAV-production 
The Noggin construct (AAV-Nog), was prepared by PCR amplification of chick cDNA 
(forward: 5’-ATG GAT CAT TCC CAG TGC CTT GTG AC-3’ and reverse: 5’-CTA GCA 
GGA GCA CTT GCA CTC CGC GAT-3’), was subcloned into the pCR2.1-TOPO plasmid 
vector (TOPO Cloning, Invitrogen) and thereafter introduced into an AAV-2-based vector 
between the 2 inverted terminal repeats and under the control of the cytomegalovirus (CMV) 
promoter using the XhoI and EcoRI sites. The AAV2/1-Noggin (called AAV-Nog) was 
produced in human embryonic kidney 293 cells by the triple-transfection method using the 
calcium phosphate precipitation technique with both the pAAV2 propeptide plasmid, the 
pXX6 plasmid coding for the adenoviral sequences essential for AAV production, and the 
pRepCAp plasmid coding for AAV1. The virus was then purified by 2 cycles of cesium 
chloride gradient centrifugation and concentrated by dialysis. The final viral preparations 
were kept in PBS solution at -80°C. The particle titer (number of viral genomes) was 
determined by quantitative PCR.   
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Table S1. Oligonucleotides used for RT-qPCR 
Gene Primer sequence (5’ 3’) Direction 
Oligonucleotide primers used for mice 
Bmp1 TTTGATGGCTACGACAGCAC Forward CTGTGGAGTGTGTCCTGGAA Reverse 
Bmp2 CATCACGAAGAAGCCGTGGA Forward TGAGAAACTCGTCACTGGGG Reverse 
Bmp4 TCCATCACGAAGAACATCTGGA Forward ATACGGTGGAAGCCCTGTTC Reverse 
Bmp5 AGGAATACACAAACAGGGATGC Forward CCAGCAGATTTTACATTGATGC Reverse 
Bmp6 GGGATGGCAGGACTGGATCA Forward ATGGTTTGGGGACGTACTCG Reverse 
Bmp7 AGCTTCGTCAACCTAGTGGAAC Forward CTGGAGCACCTGATAGACTGTG Reverse 
Bmp13 AAGACTTACTCCATTGCCGAGA Forward TCGTCCAGTCCTCTGTCTACAA Reverse 
Bmp14 ATGCTGACAGAAAGGGAGGTAA Forward GCACTGATGTCAAACACGTACC Reverse 
Alk3 TGAGACAGCAGGACCAGTCA Forward GATTCTGCCCTTGAACATGAGA Reverse 
Id1 GGTGGTACTTGGTCTGTCGG Forward CCTTGCTCACTTTGCGGTTC Reverse 
Noggin GAAGTTACAGATGTGGCTGTGG Forward CACAGACTTGGATGGCTTACAC Reverse 
Gremlin1 AGCAAAAGGGTTTTCCTGAT Forward AGTGGTCAGCATTTCACCCT Reverse 
Follistatin CCTGCTGCTGCTACTCTG Forward CTCGGTCCATGAGGTGCT Reverse 
p21 GTACTTCCTCTGCCCTGCTG Forward GGGCACTTCAGGGTTTTCTC Reverse 
p57 CTGAAGGACCAGCCTCTCTC Forward AAGAAGTCGTTCGCATTGGC Reverse 
Gapdh TGACGTGCCGCCTGGAGAAA Forward AGTGTAGCCCAAGATGCCCTTCAG Reverse 
Gapdh GCATGGCCTTCCGTGTTC Forward GGGTGGTCCAGGGTTTCTTACTC Reverse 
Oligonucleotide primers used for human cDNA insert in RS6 mice 
SMAD6 TACTCTCGGCTGTCTCCTCGC Forward CAGTGGCTCGGCTTGGTGGCG Reverse 
Oligonucleotide primers used for chick 
Noggin ATGGATCATTCCCAGTGCCTTG Forward AGCTGCCCACTTTGACGTACCG Reverse 
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